Site # 200 — New York, New York

Site # 200 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site # 200 has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 200?

Site # 200 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 200 conducted?

Site # 200 has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Site # 200 accredited by Crixeo Health?

Site # 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.